Press Releases Stevanato Group S.p.A.

Equities

STVN

IT0005452658

Market Closed - Nyse Other stock markets 01:30:02 27/04/2024 am IST			5-day change	1st Jan Change
27.54 ^USD	+0.07%		+3.03%	+0.92%

22/04	BNP Paribas Exane Initiates Stevanato Group With Outperform Rating	MT
04/04	Stevanato Group Names Ugo Gay as Chief Operations Officer	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024	26/04	BU
Stevanato S p A : AGM 2024 - Explanatory Report	24/04	PU
Stevanato S p A : Nominating and Corporate Governance Committee's Report for 2023	24/04	PU
Stevanato S p A : Report of the Audit Committee to the Shareholders on the Activities Carried Out in the Financial Year 2023	24/04	PU
Stevanato S p A : Report on Remuneration Policy and Practices for the Fiscal Year 2023	24/04	PU
Stevanato S p A : Substantiated Proposal of the Audit Committee	24/04	PU
Stevanato S p A : 2R Vials and Deep Cold Storage - Determining Mechanical & CCI performances Earnings Release	19/04	PU
Stevanato S p A : Convening Notice to the Ordinary General Meeting of Shareholders on May 24 2024	10/04	PU
Stevanato Group appoints Ugo Gay as Chief Operations Officer	04/04	BU
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares	27/03	BU
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares	22/03	BU
Stevanato Group Announces Public Offering of Ordinary Shares	21/03	BU
Stevanato S p A : Script for conference call of Stevanato Group S.p.A. discussing quarterly and year-end financial results, held on March 7, 2024 - Form 6-K	16/03	PU
Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum	12/03	BU
Stevanato: Q4 Earnings Snapshot	07/03	AQ
Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023	07/03	BU
Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024	23/02	BU
Stevanato Group Launches EZ-fill Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization	25/01	AQ
Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization	24/01	BU
Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference	04/01	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Stevanato Group S.p.A.

Equities

STVN

IT0005452658

Press Releases

Filters